mRNA疫苗递送系统研究进展

doi:10.16431/j.cnki.1671-7236.2024.11.028

Abstract

Abstract: Compared with traditional vaccines,mRNA vaccines have the advantages of easy compilation,high immunogenicity,strong safety and low production cost.The efficient delivery of mRNA to cells and successful expression is the key link for mRNA vaccines to play a role,and also the main bottleneck and pain point of mRNA vaccine research and development.Therefore,screening for cost-effective nucleic acid delivery systems is crucial for mRNA vaccine development.At present,nucleic acid delivery systems with more attention mainly include physical delivery,lipid nanoparticle delivery,polymer delivery,exosome delivery and cationic emulsion delivery.Physical delivery is basically the physical process of getting naked mRNA directly across the cell membrane into the cell.Lipid nanoparticle,polymers,exosomes and cationic emulsions protect mRNA by using themselves as delivery carriers,thereby improving delivery efficiency and reducing immune response.Based on the latest research progress of mRNA vaccines,the author summarized the application prospects and limitations of different delivery methods,and prospected their research prospects.It is expected to provide a theoretical basis for the development of a new delivery system,promote the clinical application of mRNA therapy,and provide a new mRNA vaccine solution for the prevention and treatment of more diseases.

Key words: mRNA vaccine; delivery systems; physical delivery; lipid nanoparticles; polymers

CLC Number:

S852.4

LI Ziwei, ZHANG Lei, CHEN Feng, ZHENG Hui, CUI Jin, CAO Zhenshan, ZHANG Hui, GE Shengqiang, WEI Rong, LIU Fuxiao, NAN Fulong, SHA Zhou, NI Bo. Progress on Delivery Systems of mRNA Vaccine[J]. China Animal Husbandry and Veterinary Medicine, 2024, 51(11): 4932-4942.

References

[1] POLLARD A J,BIJKER E M.A guide to vaccinology:From basic principles to new developments[J]. Nature Reviews Immunology,2021,21(2):83-100.
[2] MATSUNO Y,KANKE T,MARUYAMA N,et al.Characterization of mRNA profiles of the exosome-like vesicles in porcine follicular fluid[J].PLoS One,2019,14(6):e0217760.
[3] 汪梦竹,蒲飞洋,王慧慧,等.纳米颗粒在疫苗中的研究进展[J].生命的化学,2022,42(7):1373-1380.
WANG M Z,PU F Y,WANG H H,et al.Research progress of nanoparticles in vaccines[J].Chemistry of Life,2022,42(7):1373-1380.(in Chinese)
[4] 宋雯歌,陆璐,关亦妍,等.D-氨基酸营养缺陷型减毒鼠伤寒沙门氏菌口服疫苗的构建与评价[J].中华医院感染学杂志,2024,14:2087-2093.
SONG W G,LU L,GUAN Y Y,et al.Construction and evaluation of a D-amino acid auxotrophic attenuated oral vaccine against Salmonella Typhimurium[J].Chinese Journal of Nosocomiology,2024,14:2087-2093.(in Chinese)
[5] 关佳宁.牛结核病诊断与防控的研究进展[J].现代畜牧兽医,2024,2:83-87.
GUAN J N.Research progress in the diagnosis,prevention and control of bovine tuberculosis[J].Modern Journal of Animal Husbandry and Veterinary Medicine,2024,2:83-87.(in Chinese)
[6] CHANDLER M,JOHNSON M B,PANIGAJ M,et al.Innate immune responses triggered by nucleic acids inspire the design of immunomodulatory nucleic acid nanoparticles (NANPs)[J].Current Opinion in Biotechnology,2020,63:8-15.
[7] WOLFF J A,MALONE R W,WILLIAMS P,et al.Direct gene transfer into mouse muscle in vivo[J].Science，1990,247(4949 Pt 1):1465-1468.
[8] HOTZ C,WAGENAAR T R,GIESEKE F,et al.Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models[J].Science Translational Medicine,2021,13(610):eabc7804.
[9] MOMIN T,KANSAGRA K,PATEL H,et al.Safety and immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D):Results of an open-label,non-randomized phase Ⅰ part of phase Ⅰ/Ⅱ clinical study by intradermal route in healthy subjects in India[J].EClinicalMedicine,2021,38:101020.
[10] 张亚茹,王慧梅,迟永杰,等.mRNA疫苗及其基于聚合物的递送系统研究进展[J].中国生物工程杂志,2023,43(5):55-68.
ZHANG Y R,WANG H M,CHI Y J,et al.Research progress on mRNA vaccines and their polymer-based delivery systems[J].China Biotechnology,2023,43(5):55-68.(in Chinese)
[11] 黄可,李山红.mRNA药物研究进展及市场应用分析[J].中国生物工程杂志,2023,43(6):113-124.
HUANG K,LI S H.Research progress and market application analysis of mRNA drugs[J].China Biotechnology,2023,43(6):113-124.(in Chinese)
[12] ALFAGIH I M,ALDOSARI B,ALQUADEIB B,et al.Nanoparticles as adjuvants and nanodelivery systems for mRNA-based vaccines[J].Pharmaceutics,2020,13(1):45.
[13] BADEN L R,EL SAHLY H M,ESSINK B,et al.Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine[J].The New England Journal of Medicine,2021,384(5):403-416.
[14] TAVERNIER G,ANDRIES O,DEMEESTER J,et al.mRNA as gene therapeutic:How to control protein expression[J].Journal of Controlled Release：Official Journal of the Controlled Release Society,2011,150(3):238-247.
[15] MALONE R W,FELGNER P L,VERMA I M.Cationic liposome-mediated RNA transfection[J].Proceedings of the National Academy of Sciences of the United States of America,1989,86(16):6077-6081.
[16] TENCHOV R,BIRD R,CURTZE A E,et al.Lipid nanoparticles—From liposomes to mRNA vaccine delivery,a landscape of research diversity and advancement[J]. ACS Nano,2021,15(11):16982-17015.
[17] HOU X,ZAKS T,LANGER R,et al.Lipid nanoparticles for mRNA delivery[J].Nature Reviews Materials,2021,6(12):1078-1094.
[18] ZHANG Y,SUN C,WANG C,et al.Lipids and lipidderivatives for RNA delivery[J].Chemical Reviews,2021,121(20):12181-12277.
[19] CHAROO N A,RAHMAN Z,REPKA M A,et al.Electroporation:An avenue for transdermal drug delivery[J].Current Drug Delivery,2010,7(2):125-136.
[20] NEUMANN E,SCHAEFER-RIDDER M,WANG Y,et al.Gene transfer into mouse lyoma cells by electroporation in high electric fields[J].The EMBO Journal,1982,1(7):841-845.
[21] THOMAS C E,EHRHARDT A,KAY M A.Progress and problems with the use of viral vectors for gene therapy[J]. Nature Reviews Genetics,2003,4(5):346-358.
[22] YARMUSH M L,GOLBERG A,SERŠA G,et al.Electroporation-based technologies for medicine:Principles,applications,and challenges[J].Annual Review of Biomedical Engineering,2014,16:295-320.
[23] TODOROVIC V,KAMENSEK U,SERSA G,et al.Changing electrode orientation,but not pulse polarity,increases the efficacy of gene electrotransfer to tumors in vivo[J].Bioelectrochemistry,2014,100:119-127.
[24] DONATE A,HELLER R.Assessment of delivery parameters with the multi-electrode array for development of a DNA vaccine against Bacillus anthracis[J].Bioelectrochemistry,2013,94:1-6.
[25] ZOREC B,BECKER S,REBERŠEK M,et al.Skin electroporation for transdermal drug delivery:The influence of the order of different square wave electric pulses[J].International Journal of Pharmaceutics,2013,457(1):214-223.
[26] GOTHELF A,MAHMOOD F,DAGNAES-HANSEN F,et al.Efficacy of transgene expression in porcine skin as a function of electrode choice[J].Bioelectrochemistry,2011,82(2):95-102.
[27] FERRARO B,HELLER L C,CRUZ Y L,et al.Evaluation of delivery conditions for cutaneous plasmid electrotransfer using a multielectrode array[J].Gene Therapy,2011,18(5):496-500.
[28] MUKHERJEE P,NATHAMGARI S S P,KESSLER J A,et al.Combined numerical and experimental investigation of localized electroporation-based cell transfection and sampling[J].ACS Nano,2018,12(12):12118-12128.
[29] ITA K.Perspectives on transdermal electroporation[J].Pharmaceutics,2016,8(1)：9.
[30] DENET A R,VANBEVER R,PRÉAT V.Skin electroporation for transdermal and topical delivery[J].Advanced Drug Delivery Reviews,2004,56(5):659-674.
[31] YANG N,ZHANG C,ZHANG Y,et al.CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia[J].Journal of Translational Medicine,2024,22(1):274.
[32] TOMIZAWA M,SHINOZAKI F,MOTOYOSHI Y,et al.Sonoporation:Gene transfer using ultrasound[J].World Journal of Methodology,2013,3(4):39-44.
[33] DAFTARDAR S,NEUPANE R,BODDU SAI H S,et al.Advances in ultrasound mediated transdermal drug delivery[J]. Current Pharmaceutical Design,2019,25(4):413-423.
[34] TACHIBANA K,TACHIBANA S.Transdermal delivery of insulin by ultrasonic vibration[J].The Journal of Pharmacy and Pharmacology,1991,43(4):270-271.
[35] WANG W,LI W,MA N,et al.Non-viral gene delivery methods[J]. Current Pharmaceutical Biotechnology,2013,14(1):46-60.
[36] UNGER E C,HERSH E,VANNAN M,et al.Local drug and gene delivery through microbubbles[J].Progress in Cardiovascular Diseases,2001,44(1):45-54.
[37] PANJE C M,WANG D S,PYSZ M A,et al.Ultrasound-mediated gene delivery with cationic versus neutral microbubbles:Effect of DNA and microbubble dose on in vivo transfection efficiency[J].Theranostics,2012,2(11):1078-1091.
[38] MILLER D L,DOU C.Induction of apoptosis in sonoporation and ultrasonic gene transfer[J].Ultrasound in Medicine & Biology,2009,35(1):144-154.
[39] HOSOKAWA Y,OCHI H,IINO T,et al.Photoporation of biomolecules into single cells in living vertebrate embryos induced by a femtosecond laser amplifier[J].PLoS One,2011,6(11):e27677.
[40] RAMAMOORTH M,NARVEKAR A.Non viral vectors in gene therapy—An overview[J].Journal of Clinical and Diagnostic Research,2015,9(1):GE01-GE06.
[41] EYGERIS Y,PATEL S,JOZIC A,et al.Deconvoluting lipid nanoparticle structure for messenger RNA delivery[J].Nano Letters,2020,20(6):4543-9454.
[42] CHENG X,LEE R J.The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery[J].Advanced Drug Delivery Reviews,2016,99(Pt A):129-137.
[43] CUI L,CHEN D,ZHU L.Conformation transformation determined by different self-assembled phases in a DNA complex with cationic polyhedral oligomeric silsesquioxane lipid[J].ACS Nano,2008,2(5):921-927.
[44] KUMAR V,QIN J,JIANG Y,et al.Shielding of lipid nanoparticles for siRNA delivery:Impact on physicochemical properties,cytokine induction,and efficacy[J].Molecular Therapy Nucleic Acids,2014,3(11):e210.
[45] KOITABASHI K,NAGUMO H,NAKAO M,et al.Acidic pH-induced changes in lipid nanoparticle membrane packing[J].Biochimica et Biophysicaacta Biomembranes,2021,1863(8):183627.
[46] VERBEKE R,HOGAN M J,LORÉ K,et al.Innate immune mechanisms of mRNA vaccines[J]. Immunity,2022,55(11):1993-2005.
[47] RAMOS DA SILVA J,BITENCOURT RODRIGUES K,FORMOSO P G,et al.Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice[J].Science Translational Medicine,2023,15(686):eabn3464.
[48] REICHMUTH A M,OBERLI M A,JAKLENEC A,et al.mRNA vaccine delivery using lipid nanoparticles[J].Therapeutic Delivery,2016,7(5):319-334.
[49] VLATKOVIC I.Non-immunotherapy application of LNP-mRNA:Maximizing efficacy and safety[J].Biomedicines,2021,9(5):530.
[50] LIU S,CHENG Q,WEI T,et al.Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR-Cas gene editing[J].Nature Materials,2021,20(5):701-710.
[51] YANG T,LI C,WANG X,et al.Efficient hepatic delivery and protein expression enabled by optimized mRNA and ionizable lipid nanoparticle[J]. Bioactive Materials,2020,5(4):1053-1061.
[52] FARBER F E,MELNICK J L,BUTEL J S.Optimal conditions for uptake of exogenous DNA by Chinese hamster lung cells deficient in hypoxanthine-guanine phosphoribosyltransferase[J].Biochimica et Biophysica Acta, 1975,390(3):298-311.
[53] SHARIFNIA Z,BANDEHPOUR M,HAMISHEHKAR H,et al.In-vitro transcribed mRNA delivery using PLGA/PEI nanoparticles into human monocyte-derived dendritic cells[J]. Iranian Journal of Pharmaceutical Research,2019,18(4):1659-1675.
[54] YANG W,CHEN P,BOONSTRA E,et al.Polymeric micelles with pH-responsive cross-linked core enhance in vivo mRNA delivery[J]. Pharmaceutics,2022,14(6):1205.
[55] TARACH P,JANASZEWSKA A.Recent advances in preclinical research using PAMAM dendrimers for cancer gene therapy[J].International Journal of Molecular Sciences,2021,22(6):2912.
[56] CHEN C,YANG Z,TANG X.Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy[J]. Medicinal Research Reviews,2018,38(3):829-869.
[57] TAN L,BOGUSH N,NAQVI E,et al.Thyroid hormone plus dual-specificity phosphatase-5 siRNA increases the number of cardiac muscle cells and improves left ventricular contractile function in chronic doxorubicin-injured hearts[J].Theranostics,2021,11(10):4790-4808.
[58] XIONG H,LIU S,WEI T,et al.Theranostic dendrimer-based lipid nanoparticles containing PEGylated BODIPY dyes for tumor imaging and systemic mRNA delivery in vivo[J].Journal of Controlled Release,2020,325:198-205.
[59] LI M,ZHOU H,JIANG W,et al.Nanovaccines integrating endogenous antigens and pathogenic adjuvants elicit potent antitumor immunity[J].Nano Today,2020,35：10100701-10100712.
[60] WU Z W,CHIEN C T,LIU C Y,et al.Recent progress in copolymer-mediated siRNA delivery[J].Journal of Drug Targeting,2012,20(7):551-560.
[61] WANG F,ULLAH A,FAN X,et al.Delivery of nanoparticle antigens to antigen-presenting cells:From extracellular specific targeting to intracellular responsive presentation[J].Journal of Controlled Release,2021,333:107-128.
[62] LU B,WANG C F,WU D Q,et al.Chitosan based oligoamine polymers:Synthesis,characterization,and gene delivery[J]. Journal of Controlled Release,2009,137(1):54-62.
[63] VALADI H,EKSTROEM K,BOSSIOS A,et al.Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells[J].Nature Cell Biology,2007,9(6):654-659.
[64] LI Y,ZHAO J,YU S,et al.Extracellular vesicles long RNA sequencing reveals abundant mRNA,circRNA,and lncRNA in human blood as potential biomarkers for cancer diagnosis[J].Clinical Chemistry,2019,65(6):798-808.
[65] CHOI W,CHO J H,PARK S H,et al.Ginseng root-derived exosome-like nanoparticles protect skin from UV irradiation and oxidative stress by suppressing activator protein-1 signaling and limiting the generation of reactive oxygen species[J]. Journal of Ginseng Research,2024,48(2):211-219.
[66] SOLTANI F,PARHIZ H,MOKHTARZADEH A,et al.Synthetic and biological vesicular nano-carriers designed for gene delivery[J]. Current Pharmaceutical Design,2015,21(42):6214-6235.
[67] HANEY M J,KLYACHKO N L,ZHAO Y,et al.Exosomes as drug delivery vehicles for Parkinson’s disease therapy[J].Journal of Controlled Release,2015,207:18-30.
[68] KIM H,JANG H,CHO H,et al.Recent advances in exosome-based drug delivery for cancer therapy[J].Cancers,2021,13(17):4435.
[69] TSAI S J,ATAI N A,CACCIOTTOLO M,et al.Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity[J].The Journal of Biological Chemistry,2021,297(5):101266.
[70] KIM H,KIM E H,KWAK G,et al.Exosomes:Cell-derived nanoplatforms for the delivery of cancer therapeutics[J].International Journal of Molecular Sciences,2020,22(1):14.
[71] SUN D,ZHUANG X,XIANG X,et al.A novel nanoparticle drug delivery system:The anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes[J].Molecular Therapy,2010,18(9):1606-1614.
[72] KOJIMA R,BOJAR D,RIZZI G,et al.Designer exosomes produced by implanted cells intracerebrallydeliver therapeutic cargo for Parkinson’s disease treatment[J].Nature Communications,2018,9(1):1305.
[73] QIAO L,HU S,HUANG K,et al.Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs[J].Theranostics,2020,10(8):3474-3487.
[74] LI X,TSIBOUKLIS J,WENG T,et al.Nano carriers for drug transport across the blood-brain barrier[J].Journal of Drug Targeting,2017,25(1):17-28.
[75] ZHANG W,JIANG Y,HE Y,et al.Lipid carriers for mRNA delivery[J]. Acta Pharmaceutica Sinica B,2023,13(10):4105-4126.
[76] ZHU W,HUANG L,LI Y,et al.Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo[J]. Cancer Letters,2012,315(1):28-37.
[77] RITPRAJAK P,HASHIGUCHI M,AZUMA M.Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells[J].Molecular Therapy,2008,16(7):1323-1330.
[78] KANG H S,JIN S J,MYUNG C S,et al.Delivery of interleukin-18 gene to lung cancer cells using cationic emulsion[J].Journal of Drug Targeting,2009,17(1):19-28.
[79] DONAHUE D A,BALLESTEROS C,MARUGGI G,et al.Nonclinical safety assessment of lipid nanoparticle-and emulsion-based self-amplifying mRNA vaccines in rats[J].International Journal of Toxicology,2023,42(1):37-49.
[80] BOGAERT B,DEBISSCHOP A,EHOUARNE T,et al.Selective replacement of cholesterol with cationic amphiphilic drugs enables the design of lipid nanoparticles with improved RNA delivery[J]. Nano Letters,2024,24(10):2961-2971.
[81] ONGUN M,LOKRAS A G,BAGHEL S,et al.Lipid nanoparticles for local delivery of mRNA to the respiratory tract:Effect of PEG-lipid content and administration route[J].European Journal of Pharmaceutics and Biopharmaceutics,2024,198:114266.
[82] DOAN T N K,DAVIS M M,CROYLE M A.Identification of film-based formulations that move mRNA lipid nanoparticles out of the freezer[J].Molecular Therapy Nucleic Acids,2024,35(2):102179.
[83] ZHANG P,FALCONE S,TSYBOVSKY Y,et al.Increased neutralization potency and breadth elicited by a SARS-CoV-2 mRNA vaccine forming virus-like particles[J].Proceedings of the National Academy of Sciences of the United States of America,2023,120(29):e2305896120.
[84] ZHANG X,SU K,WU S,et al.One-component cationic lipids for systemic mRNA delivery to splenic T cells[J].Angewandte Chemie-international Edition,2024，63(26):e202405444.
[85] RENEER Z B,BERGERON H C,REYNOLDS S,et al.mRNA vaccines encoding Influenza virus hemagglutinin (HA) elicits immunity in mice from Influenza A virus challenge[J].PLoS One,2024,19(4):e0297833.
[86] SHAW C A,ESSINK B,HARPER C,et al.Safety and immunogenicity of an mRNA-based RSV vaccine including a 12-month booster in a phase Ⅰclinical trial in healthy older adults[J].The Journal of Infectious Diseases,2024，22:jiae081.
[87] TAI W,ZHENG J,ZHANG X,et al.MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection[J].Virus Research, 2023,334:199156.
[88] GERHARDS C,THIAUCOURT M,HETJENS M,et al.Heterologous vector-mRNA based SARS-CoV-2 vaccination strategy appears superior to a homologous vector-based vaccination scheme in German healthcare workers regarding humoral SARS-CoV-2 response indicating a high boosting effect by mRNA vaccines[J].Vaccines,2023,11(3):701.
[89] SCARIA P V,ROTH N,SCHWENDT K,et al.mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response[J]. NPJ Vaccines,2024,9(1):9.
[90] LI J,WU Y,XIANG J,et al.Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines[J]. Chemical Engineering Journal,2023,456:140930.
[91] SEBASTIAN M,SCHRÖDER A,SCHEEL B,et al.A phase Ⅰ/Ⅱa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage ⅢB/Ⅳ non-small cell lung cancer[J].Cancer Immunology,Immunotherapy,2019,68(5):799-812.
[92] SONG J,LUO N,DONG L,et al.RNA base editors:The emerging approach of RNA therapeutics[J].Wiley Interdisciplinary Reviews RNA,2024,15(2):e1844.

Progress on Delivery Systems of mRNA Vaccine

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 1

Recommended Articles 0

Metrics

Comments